BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8217234)

  • 21. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: analysis of 117 cases from a single institution.
    Esteve J; López-Guillermo A; Martínez-Francés A; Bosch F; Terol MJ; Campo E; Montserrat E; Rozman C
    Eur J Haematol; 1995 Oct; 55(4):217-22. PubMed ID: 7589337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in head and neck non-Hodgkin's lymphoma with special reference to serum lactic dehydrogenase and serum copper.
    Hisamitsu S; Shibuya H; Hoshina M; Horiuchi J
    Acta Oncol; 1990; 29(7):879-83. PubMed ID: 2261202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
    Wheeler C; Strawderman M; Ayash L; Churchill WH; Bierer BE; Elias A; Gilliland DG; Antman K; Guinan EC; Eder JP
    J Clin Oncol; 1993 Jun; 11(6):1085-91. PubMed ID: 8099120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group.
    Tsang RW; Gospodarowicz MK; Sutcliffe SB; Sturgeon JF; Panzarella T; Patterson BJ
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):599-604. PubMed ID: 8226154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of survival in mantle cell lymphoma.
    Zucca E; Roggero E; Pinotti G; Pedrinis E; Cappella C; Venco A; Cavalli F
    Ann Oncol; 1995 Mar; 6(3):257-62. PubMed ID: 7612491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation.
    de Kreuk M; Ossenkoppele GJ; Meijer CJ; Huijgens PC
    Bone Marrow Transplant; 1996 Jun; 17(6):963-71. PubMed ID: 8807101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
    Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
    Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
    García R; Hernández JM; Caballero MD; González M; Galende J; del Cañizo MC; Vázquez L; San Miguel JF
    Br J Cancer; 1993 Dec; 68(6):1227-31. PubMed ID: 8260377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
    Heinz R; Hanak H; Stacher A
    Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.
    Steward WP; Todd ID; Harris M; Jones JM; Blackledge G; Wagstaff J; Anderson H; Wilkinson PM; Crowther D
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):881-9. PubMed ID: 6547675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis analysis of 53 cases with primary intestinal non-Hodgkin's lymphoma].
    Xiang XJ; He YJ; Li YH; Huang HQ; Xia ZJ; Huang H
    Ai Zheng; 2004 Apr; 23(4):443-7. PubMed ID: 15087036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A predictive model for aggressive non-Hodgkin's lymphoma.
    International Non-Hodgkin's Lymphoma Prognostic Factors Project
    N Engl J Med; 1993 Sep; 329(14):987-94. PubMed ID: 8141877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
    Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
    Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
    Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
    Azab MB; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset JM; Caillou B; Droz JP
    Cancer; 1989 Sep; 64(6):1208-17. PubMed ID: 2670184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].
    Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
    Acta Med Croatica; 2003; 57(4):261-7. PubMed ID: 14639859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.